ALEXANDR GALKIN: Open Payments
NPI 1710607080 · ENDWELL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$514 in 27 payments from 13 companies in 2025. Trend: 2023 $184 · 2024 $334 · 2025 $514
Food & beverage: $514
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $77 |
| Phathom Pharmaceuticals, Inc. | 4 | $69 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Novo Nordisk Inc | 3 | $57 |
| Daiichi Sankyo Inc. | 2 | $55 |
| Inspire Medical Systems, Inc. | 2 | $47 |
| Lilly USA, LLC | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Exact Sciences Corporation | 1 | $21 |
| Abbott Laboratories | 1 | $17 |
Products named: VOQUEZNA, QULIPTA, INJECTAFER, INSPIRE, MOUNJARO, Ozempic, BREZTRI, TRELEGY ELLIPTA.
Industry payments across NY — which companies pay providers there.
